Experts are actively investigating a potential metabolic protocol involving the combined usage of Dulaglutide, a dual GIP/GLP-1 receptor activator; Retatrutide, an experimental triple GIP/GLP-1/GCG receptor stimulant; https://biopeptidestore.com/